At the bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer

Journal of Leukocyte Biology

Volumn 96, Issue 2, 2014, Pages 201-212

  Hardbower, Dana M ^a   Peek Jr , Richard M ^a,b   Wilson, Keith T ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Veterans Affairs   (United States)

Author keywords

Carcinogenesis; DFMO; Oxidative stress

Indexed keywords

ACECAINIDE; CAGA PROTEIN; CATALASE; GAMMA CHEMOKINE; INTERLEUKIN 17; INTERLEUKIN 8; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; SUPEROXIDE DISMUTASE; UREASE; VACUOLATING TOXIN;

ADAPTIVE IMMUNITY; APOPTOSIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BASIC RESEARCH; CELL GROWTH; CELL MOTILITY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; DNA DAMAGE; DNA REPAIR; EXCISION REPAIR; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INNATE IMMUNITY; MITOCHONDRIAL MEMBRANE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; POLYAMINE METABOLISM; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY BURST; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TRANSLATIONAL RESEARCH; TYPE IV SECRETION SYSTEM;

CARCINOGENESIS; DFMO; OXIDATIVE STRESS;

DNA DAMAGE; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; STOMACH NEOPLASMS;

EID: 84905059793     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.4BT0214-099R     Document Type: Review

References (105)

1. Parsonnet, J., Friedman, G. D., Vandersteen, D. P., Chang, Y., Vogelman, J. H., Orentreich, N., Sibley, R. K. (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325, 1127-1131.
2. Nomura, A., Stemmermann, G., Chyou, P., Kato, I., Perez-Perez, G., Blaser, M. (1991) Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 325, 1132-1136.
3. Peek, R. M., Blaser, M. J. (2002) Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2, 28-37.
4. Peek, R.M., Blaser, M.J. (1994) Infection with Helicobacter pylori. IARC Monogr. Eval. Carcinog. Risks Hum. 61, 177-240.
5. De Sablet, T., Piazuelo, M. B., Shaffer, C. L., Schneider, B. G., Asim, M., Chaturvedi, R., Bravo, L. E., Sicinschi, L. A., Delgado, A. G., Mera, R. M., Israel, D. A., Romero-Gallo, J., Peek, R. M., Cover, T. L., Correa, P., Wilson, K. T. (2011) Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 60, 1189-1195.
6. Blaser, M. J., Perez-Perez, G. I., Kleanthous, H., Cover, T. L., Peek, R. M., Chyou, P. H., Stemmermann, G. N., Nomura, A. (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55, 2111-2115.
7. Zambon, C. F., Basso, D., Navaglia, F., Belluco, C., Falda, A., Fogar, P., Greco, E., Gallo, N., Rugge, M., Di Mario, F., Plebani, M. (2005) Proand anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 29, 141-152.
8. Peek, R. M., Fiske, C., Wilson, K. T. (2010) Role of innate immunity in Helicobacter pylori-induced gastric malignancy. Phys. Rev. 90, 831-858.
9. Wilson, K. T., Crabtree, J. E. (2007) Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies. Gastroenterology 133, 288-308.
10. Augusto, A. C., Miguel, F., Mendonça, S., Pedrazzoli Jr., J., Gurgueira, S. A. (2007) Oxidative stress expression status associated to Helicobacter pylori virulence in gastric diseases. Clin. Biochem. 40, 615-622.
11. Chaturvedi, R., de Sablet, T., Coburn, L. A., Gobert, A. P., Wilson, K. T. (2012) Arginine and polyamines in Helicobacter pylori-induced immune dysregulation and gastric carcinogenesis. Amino Acids 42, 627-640.
12. Ramarao, N., Gray-Owen, S. D., Meyer, T. F. (2000) Helicobacter pylori induces but survives the extracellular release of oxygen radicals from professional phagocytes using its catalase activity. Mol. Microbiol. 38, 103-113.
13. Touati, E., Michel, V., Thiberge, J-M., Wuscher, N., Huerre, M., Labigne, A. (2003) Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 124, 1408-1419.
14. Xu, H., Chaturvedi, R., Cheng, Y., Bussière, F. I., Asim, M., Yao, M. D., Potosky, D., Meltzer, S. J., Rhee, J. G., Kim, S. S., Moss, S. F., Hacker, A., Wang, Y., Casero, R. A., Wilson, K. T. (2004) Spermine oxidation induced by Helicobacter pylori results in apoptosis and DNA damage: implications for gastric carcinogenesis. Cancer Res. 64, 8521-8525.
15. Busler, V. J., Torres, V. J., McClain, M. S., Tirado, O., Friedman, D. B., Cover, T. L. (2006) Protein-protein interactions among Helicobacter pylori cag proteins. J. Bacteriol. 188, 4787-4800.
16. Lin, W. C., Tsai, H. F., Kuo, S. H., Wu, M. S., Lin, C. W., Hsu, P. I., Cheng, A. L., Hsu, P. N. (2010) Translocation of Helicobacter pylori CagA into human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma. Cancer Res. 70, 5740-5748.
17. Murata-Kamiya, N. (2011) Pathophysiological functions of the CagA oncoprotein during infection by Helicobacter pylori. Microbes Infect. 13, 799-807.
18. Fajardo, C. A., Quiroga, A. J., Coronado, A., Labrador, K., Acosta, N., Delgado, P., Jaramillo, C., Bravo, M. M. (2013) CagA EPIYA polymorphisms in Colombian Helicobacter pylori strains and their influence on disease-associated cellular responses. World J. Gastrointest. Oncol. 5, 50-59.
19. Eftang, L. L., Esbensen, Y., Tannaes, T. M., Bukholm, I. R., Bukholm, G. (2012) Interleukin-8 is the single most up-regulated gene in whole genome profiling of H. pylori exposed gastric epithelial cells. BMC Microbiol. 12, 9.
20. Peek R. M., Jr., Miller, G. G., Tham, K. T., Perez-Perez, G. I., Zhao, X., Atherton, J. C., Blaser, M. J. (1995) Heightened inflammatory response and cytokine expression in vivo to cagA+ Helicobacter pylori strains. Lab. Invest. 73, 760-770.
21. Chaturvedi, R., Asim, M., Romero-Gallo, J., Barry, D. P., Hoge, S., de Sablet, T., Delgado, A. G., Wroblewski, L. E., Piazuelo, M. B., Yan, F., Israel, D. A., Casero R. A., Jr., Correa, P., Gobert, A. P., Polk, D. B., Peek R. M., Jr., Wilson, K. T. (2011) Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology 141, 1696. e2-1708. e2.
22. Croce, C. M. (2008) Oncogenes and cancer. N. Engl. J. Med. 358, 502-511.
23. Kodaman, N., Pazos, A., Schneider, B. G., Piazuelo, M. B., Mera, R., Sobota, R. S., Sicinschi, L. A., Shaffer, C. L., Romero-Gallo, J., de Sablet, T., Harder, R. H., Bravo, L. E., Peek R. M., Jr., Wilson, K. T., Cover, T. L., Williams, S. M., Correa, P. (2014) Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc. Natl. Acad. Sci. USA 111, 1455-1460.
24. Raju, D., Hussey, S., Ang, M., Terebiznik, M. R., Sibony, M., Galindo-Mata, E., Gupta, V., Blanke, S. R., Delgado, A., Romero-Gallo, J., Ramjeet, M. S., Mascarenhas, H., Peek, R. M., Correa, P., Streutker, C., Hold, G., Kunstmann, E., Yoshimori, T., Silverberg, M. S., Girardin, S. E., Philpott, D. J., El Omar, E., Jones, N. L. (2012) Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 142, 1160-1171.
25. 2+ influx, mitochondrial reactive oxygen intermediates, and NF-κB activation. Infect. Immun. 75, 3373-3381.
26. Tsugawa, H., Suzuki, H., Saya, H., Hatakeyama, M., Hirayama, T., Hirata, K., Nagano, O., Matsuzaki, J., Hibi, T. (2012) Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell. Host Microbe 12, 764-777.
27. Willhite, D. C., Blanke, S. R. (2004) Helicobacter pylori vacuolating cytotoxin enters cells, localizes to the mitochondria, and induces mitochondrial membrane permeability changes correlated to toxin channel activity. Cell. Microbiol. 6, 143-154.
28. Eruslanov, E., Kusmartsev, S. (2010) Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol. Biol. 594, 57-72.
29. Wang, G., Hong, Y., Olczak, A., Maier, S. E., Maier, R. J. (2006) Dual roles of Helicobacter pylori NapA in inducing and combating oxidative stress. Infect. Immun. 74, 6839-6846.
30. Uberti, A. F., Olivera-Severo, D., Wassermann, G. E., Scopel-Guerra, A., Moraes, J. A., Barcellos-de-Souza, P., Barja-Fidalgo, C., Carlini, C. R. (2013) Pro-inflammatory properties and neutrophil activation by Helicobacter pylori urease. Toxicon 260, 240-249.
31. Gobert, A. P., Mersey, B. D., Cheng, Y., Blumberg, D. R., Newton, J. C., Wilson, K. T. (2002) Cutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J. Immunol. 168, 6002-6006.
32. Gong, M., Ling, S. S. M., Lui, S. Y., Yeoh, K. G., Ho, B. (2010) Helicobacter pylori γ-glutamyl transpeptidase is a pathogenic factor in the development of peptic ulcer disease. Gastroenterology 139, 564-573.
33. Asfaha, S., Dubeykovskiy, A. N., Tomita, H., Yang, X., Stokes, S., Shibata, W., Friedman, R. A., Ariyama, H., Dubeykovskaya, Z. A., Muthupalani, S., Ericksen, R., Frucht, H., Fox, J. G., Wang, T. C. (2013) Mice that express human interleukin-8 have increased mobilization of immature myeloid cells, which exacerbates inflammation and accelerates colon carcinogenesis. Gastroenterology 144, 155-166.
34. Fu, S., Ramanujam, K. S., Wong, A., Fantry, G. T., Drachenberg, C. B., James, S. P., Meltzer, S. J., Wilson, K. T. (1999) Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. Gastroenterology 116, 1319-1329.
35. Li, M., Zhang, Y., Feurino, L. W., Wang, H., Fisher, W. E., Brunicardi, F. C., Chen, C., Yao, Q. (2008) Interleukin-8 increases vascular endothelial growth factor and neuropilin expression and stimulates ERK activation in human pancreatic cancer. Cancer Sci. 99, 733-737.
36. Wang, Y., Xu, R. C., Zhang, X. L., Niu, X. L., Qu, Y., Li, L. Z., Meng, X. Y. (2012) Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion. Cytokine 59, 145-155.
37. Mangerich, A., Knutson, C. G., Parry, N. M., Muthupalani, S., Ye, W., Prestwich, E., Cui, L., McFaline, J. L., Mobley, M., Ge, Z., Taghizadeh, K., Wishnok, J. S., Wogan, G. N., Fox, J. G., Tannenbaum, S. R., Dedon, P. C. (2012) Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc. Natl. Acad. Sci. USA 109, E1820-E1829.
38. Meira, L. B., Bugni, J. M., Green, S. L., Lee, C-W., Pang, B., Borenshtein, D., Rickman, B. H., Rogers, A. B., Moroski-Erkul, C. A., McFaline, J. L., Schauer, D. B., Dedon, P. C., Fox, J. G., Samson, L. D. (2008) DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J. Clin. Invest. 118, 2516-2525.
39. Terebiznik, M. R., Vazquez, C. L., Torbicki, K., Banks, D., Wang, T., Hong, W., Blanke, S. R., Colombo, M. I., Jones, N. L. (2006) Helicobacter pylori VacA toxin promotes bacterial intracellular survival in gastric epithelial cells. Infect. Immun. 74, 6599-6614.
40. Wilson, K. T., Ramanujam, K. S., Mobley, H. L., Musselman, R. F., James, S. P., Meltzer, S. J. (1996) Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology 111, 1524-1533.
41. Gobert, A. P., Asim, M., Piazuelo, M. B., Verriere, T., Scull, B. P., de Sablet, T., Glumac, A., Lewis, N. D., Correa, P., Peek, R. M., Chaturvedi, R., Wilson, K. T. (2011) Disruption of nitric oxide signaling by Helicobacter pylori results in enhanced inflammation by inhibition of heme oxygenase-1. J. Immunol. 187, 5370-5379.
42. Chaturvedi, R., Asim, M., Hoge, S., Lewis, N. D., Singh, K., Barry, D. P., de Sablet, T., Piazuelo, M. B., Sarvaria, A. R., Cheng, Y., Closs, E. I., Casero R. A., Jr., Gobert, A. P., Wilson, K. T. (2010) Polyamines impair immunity to Helicobacter pylori by inhibiting L-arginine uptake required for nitric oxide production. Gastroenterology 139, 1686. e6-1698. e6.
43. Katsurahara, M., Kobayashi, Y., Iwasa, M., Ma, N., Inoue, H., Fujita, N., Tanaka, K., Horiki, N., Gabazza, E. C., Takei, Y. (2009) Reactive nitrogen species mediate DNA damage in Helicobacter pylori-infected gastric mucosa. Helicobacter 14, 552-558.
44. Gobert, A. P., Cheng, Y., Wang, J-Y., Boucher, J-L., Iyer, R. K., Cederbaum, S. D., Casero, R. A., Newton, J. C., Wilson, K. T. (2002) Helicobacter pylori induces macrophage apoptosis by activation of arginase II. J. Immunol. 168, 4692-4700.
45. Asim, M., Chaturvedi, R., Hoge, S., Lewis, N. D., Singh, K., Barry, D. P., Algood, H. S., de Sablet, T., Gobert, A. P., Wilson, K. T. (2010) Helicobacter pylori induces ERK-dependent formation of a phospho-c-fos/c-jun activator protein-1 complex that causes apoptosis in macrophages. J. Biol. Chem. 285, 20343-20357.
46. Cheng, Y., Chaturvedi, R., Asim, M., Bussiere, F. I., Scholz, A., Xu, H., Casero R. A., Jr., Wilson, K. T. (2005) Helicobacter pylori-induced macrophage apoptosis requires activation of ornithine decarboxylase by c-Myc. J. Biol. Chem. 280, 22492-22496.
47. Chaturvedi, R., Cheng, Y., Asim, M., Bussièe, F. I., Xu, H., Gobert, A. P., Hacker, A., Casero, R. A., Wilson, K. T. (2004) Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization. J. Biol. Chem. 279, 40161-40173.
48. Lewis, N. D., Asim, M., Barry, D. P., de Sablet, T., Singh, K., Piazuelo, M. B., Gobert, A. P., Chaturvedi, R., Wilson, K. T. (2011) Immune evasion by Helicobacter pylori is mediated by induction of macrophage arginase II. J. Immunol. 186, 3632-3641.
49. Mosser, D. M., Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
50. Wroblewski, L. E., Peek R. M., Jr., Wilson, K. T. (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol. Rev. 23, 713-739.
51. Kao, J. Y., Zhang, M., Miller, M. J., Mills, J. C., Wang, B., Liu, M., Eaton, K. A., Zou, W., Berndt, B. E., Cole, T. S., Takeuchi, T., Owyang, S. Y., Luther, J. (2010) Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 138, 1046-1054.
52. Gray, B. M., Fontaine, C. A., Poe, S. A., Eaton, K. A. (2013) Complex T cell interactions contribute to Helicobacter pylori gastritis in mice. Infect. Immun. 81, 740-752.
53. Eaton, K. A., Mefford, M., Thevenot, T. (2001) The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J. Immunol. 166, 7456-7461.
54. Shi, Y., Liu, X. F., Zhuang, Y., Zhang, J. Y., Liu, T., Yin, Z., Wu, C., Mao, X. H., Jia, K. R., Wang, F. J., Guo, H., Flavell, R. A., Zhao, Z., Liu, K. Y., Xiao, B., Guo, Y., Zhang, W. J., Zhou, W. Y., Guo, G., Zou, Q. M. (2010) Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J. Immunol. 184, 5121-5129.
55. D'Elios, M. M., Manghetti, M., De Carli, M., Costa, F., Baldari, C. T., Burroni, D., Telford, J. L., Romagnani, S., Del Prete, G. (1997) T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J. Immunol. 158, 962-967.
56. Luzza, F., Parrello, T., Monteleone, G., Sebkova, L., Romano, M., Zarrilli, R., Imeneo, M., Pallone, F. (2000) Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J. Immunol. 165, 5332-5337.
57. Peterson II, R. A., Hoepf, T., Eaton, K. A. (2003) Adoptive transfer of splenocytes in SCID mice implicates CD4+ T cells in apoptosis and epithelial proliferation associated with Helicobacter pylori-induced gastritis. Comp. Med. 53, 498-509.
58. Muller, A., Solnick, J. V. (2011) Inflammation, immunity, and vaccine development for Helicobacter pylori. Helicobacter 16 (Suppl. 1), 26-32.
59. Lundgren, A., Stromberg, E., Sjoling, A., Lindholm, C., Enarsson, K., Edebo, A., Johnsson, E., Suri-Payer, E., Larsson, P., Rudin, A., Svennerholm, A. M., Lundin, B. S. (2005) Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. Infect. Immun. 73, 523-531.
60. Robinson, K., Kenefeck, R., Pidgeon, E. L., Shakib, S., Patel, S., Polson, R. J., Zaitoun, A. M., Atherton, J. C. (2008) Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses. Gut 57, 1375-1385.
61. Wang, Y. H., Gorvel, J. P., Chu, Y. T., Wu, J. J., Lei, H. Y. (2010) Helicobacter pylori impairs murine dendritic cell responses to infection. PLoS One 5, e10844.
62. Bedoya, A., Garay, J., Sanzon, F., Bravo, L. E., Bravo, J. C., Correa, H., Craver, R., Fontham, E., Du, J. X., Correa, P. (2003) Histopathology of gastritis in Helicobacter pylori-infected children from populations at high and low gastric cancer risk. Hum. Pathol. 34, 206-213.
63. Harris, P. R., Wright, S. W., Serrano, C., Riera, F., Duarte, I., Torres, J., Pena, A., Rollan, A., Viviani, P., Guiraldes, E., Schmitz, J. M., Lorenz, R. G., Novak, L., Smythies, L. E., Smith, P. D. (2008) Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. Gastroenterology 134, 491-499.
64. Serrano, C., Wright, S. W., Bimczok, D., Shaffer, C. L., Cover, T. L., Venegas, A., Salazar, M. G., Smythies, L. E., Harris, P. R., Smith, P. D. (2013) Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori-infected children. Mucosal Immunol. 6, 950-959.
65. Uehara, T., Ma, D., Yao, Y., Lynch, J. P., Morales, K., Ziober, A., Feldman, M., Ota, H., Sepulveda, A. R. (2013) H. pylori infection is associated with DNA damage of Lgr5-positive epithelial stem cells in the stomach of patients with gastric cancer. Dig. Dis. Sci. 58, 140-149.
66. Davies, G. R., Banatvala, N., Collins, C. E., Sheaff, M. T., Abdi, Y., Clements, L., Rampton, D. S. (1994) Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand. J. Gastroenterol. 29, 419-424.
67. Bagchi, D., Bhattacharya, G., Stohs, S. J. (1996) Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic. Res. 24, 439-450.
68. Mannick, E. E., Bravo, L. E., Zarama, G., Realpe, J. L., Zhang, X. J., Ruiz, B., Fontham, E. T., Mera, R., Miller, M. J., Correa, P. (1996) Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 56, 3238-3243.
69. Baik, S. C., Youn, H. S., Chung, M. H., Lee, W. K., Cho, M. J., Ko, G. H., Park, C. K., Kasai, H., Rhee, K. H. (1996) Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res. 56, 1279-1282.
70. Obst, B., Wagner, S., Sewing, K. F., Beil, W. (2000) Helicobacter pylori causes DNA damage in gastric epithelial cells. Carcinogenesis 21, 1111-1115.
71. Jenks, P. J., Jeremy, A. H., Robinson, P. A., Walker, M. M., Crabtree, J. E. (2003) Long-term infection with Helicobacter felis and inactivation of the tumour suppressor gene p53 cumulatively enhance the gastric mutation frequency in Big Blue® transgenic mice. J. Pathol. 201, 596-602.
72. Touati, E., Michel, V., Thiberge, J-M., Avé, P., Huerre, M., Bourgade, F., Klungland, A., Labigne, A. (2006) Deficiency in OGG1 protects against inflammation and mutagenic effects associated with H. pylori infection in mouse. Helicobacter 11, 494-505.
73. Toller, I. M., Neelsen, K. J., Steger, M., Hartung, M. L., Hottiger, M. O., Stucki, M., Kalali, B., Gerhard, M., Sartori, A. A., Lopes, M., Müller, A. (2011) Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc. Natl. Acad. Sci. USA 108, 14944-14949.
74. Kim, J. J., Tao, H., Carloni, E., Leung, W. K., Graham, D. Y., Sepulveda, A. R. (2002) Helicobacter pylori impairs DNA mismatch repair in gastric epithelial cells. Gastroenterology 123, 542-553.
75. Machado, A. M. D., Figueiredo, C., Touati, E., Máximo, V., Sousa, S., Michel, V., Carneiro, F., Nielsen, F. C., Seruca, R., Rasmussen, L. J. (2009) Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin. Cancer Res. 15, 2995-3002.
76. 2 increase AP endonuclease-1/redox factor-1 expression in human gastric epithelial cells. Gastroenterology 127, 845-858.
77. Bhattacharyya, A., Chattopadhyay, R., Burnette, B. R., Cross, J. V., Mitra, S., Ernst, P. B., Bhakat, K. K., Crowe, S. E. (2009) Acetylation of apurinic/apyrimidinic endonuclease-1 regulates Helicobacter pylori-mediated gastric epithelial cell apoptosis. Gastroenterology 136, 2258-2269.
78. Chaturvedi, R., de Sablet, T., Peek, R. M., Wilson, K. T. (2012) Spermine oxidase, a polyamine catabolic enzyme that links Helicobacter pylori CagA and gastric cancer risk. Gut Microbes 3, 48-56.
79. Chaturvedi, R., Asim, M., Piazuelo, M. B., Yan, F., Barry, D. P., Sierra, J. C., Delgado, A. G., Hill, S., Casero R. A., Jr., Bravo, L. E., Dominguez, R. L., Correa, P., Polk, D. B., Washington, M. K., Rose, K. L., Schey, K. L., Morgan, D. R., Peek, R. M., Wilson, K. T. (2014) Activation of EGFR and ErbB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage. Gastroenterology. doi: http://dx.doi.org/10.1053/j.gastro. 2014. 02. 005. [Epub ahead of print].
80. Borrego, S., Vazquez, A., Dasí, F., Cerdá, C., Iradi, A., Tormos, C., Sánchez, J., Bagán, L., Boix, J., Zaragoza, C., Camps, J., Saèz, G. (2013) Oxidative stress and DNA damage in human gastric carcinoma: 8-oxo-7=8-dihydro-2=-deoxyguanosine (8-oxo-dG) as a possible tumor marker. Intl. J. Mol. Sci. 14, 3467-3486.
81. Hardbower, D. M., de Sablet, T., Chaturvedi, R., Wilson, K. T. (2013) Chronic inflammation and oxidative stress: the smoking gun for Helicobacter pylori-induced gastric cancer? Gut Microbe 4, 1-7.
82. Gobert, A. P., McGee, D. J., Akhtar, M., Mendz, G. L., Newton, J. C., Cheng, Y., Mobley, H. L., Wilson, K. T. (2001) Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc. Natl. Acad. Sci. USA 98, 13844-13849.
83. Parsonnet, J., Friedman, G. D., Orentreich, N., Vogelman, H. (1997) Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40, 297-301.
84. Mera, R., Fontham, E. T., Bravo, L. E., Bravo, J. C., Piazuelo, M. B., Camargo, M. C., Correa, P. (2005) Long term follow up of patients treated for Helicobacter pylori infection. Gut 54, 1536-1540.
85. Morgan, D. R., Torres, J., Sexton, R., Herrero, R., Salazar-Martinez, E., Greenberg, E. R., Bravo, L. E., Dominguez, R. L., Ferreccio, C., Lazcano-Ponce, E. C., Meza-Montenegro, M. M., Pena, E. M., Pena, R., Correa, P., Martinez, M. E., Chey, W. D., Valdivieso, M., Anderson, G. L., Goodman, G. E., Crowley, J. J., Baker, L. H. (2013) Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA 309, 578-586.
86. Meyskens F. L., Jr., McLaren, C. E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P. M., Hawk, E., Kelloff, G., Lawson, M. J., Kidao, J., Mc-Cracken, J., Albers, C. G., Ahnen, D. J., Turgeon, D. K., Goldschmid, S., Lance, P., Hagedorn, C. H., Gillen, D. L., Gerner, E. W. (2008) Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev. Res. 1, 32-38.
87. Meyskens F. L., Jr., Gerner, E. W., Emerson, S., Pelot, D., Durbin, T., Doyle, K., Lagerberg, W. (1998) Effect of α-difluoromethylornithine on rectal mucosal levels of polyamines in a randomized, double-blinded trial for colon cancer prevention. J. Natl. Cancer Inst. 90, 1212-1218.
88. Zell, J. A., McLaren, C. E., Chen, W. P., Thompson, P. A., Gerner, E. W., Meyskens, F. L. (2010) Ornithine decarboxylase-1 polymorphism, chemoprevention with eflornithine and sulindac, and outcomes among colorectal adenoma patients. J. Natl. Cancer Inst. 102, 1513-1516.
89. Witherspoon, M., Chen, Q., Kopelovich, L., Gross, S. S., Lipkin, S. M. (2013) Unbiased metabolite profiling indicates that a diminished thymidine pool is the underlying mechanism of colon cancer chemoprevention by α-difluoromethylornithine. Cancer Discov. 3, 1072-1081.
90. Casero R. A., Jr., (2013) Say what? The activity of the polyamine biosynthesis inhibitor difluoromethylornithine in chemoprevention is a result of reduced thymidine pools? Cancer Discov. 3, 975-977.
91. Barry, D. P., Asim, M., Leiman, D. A., de Sablet, T., Singh, K., Casero R. A., Jr., Chaturvedi, R., Wilson, K. T. (2011) Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. PLoS One 6, e17510.
92. Ryter, S. W., Alam, J., Choi, A. M. (2006) Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Phys. Rev. 86, 583-650.
93. Gobert, A. P., Verriere, T., de Sablet, T., Peek, R. M., Chaturvedi, R., Wilson, K. T. (2013) Haem oxygenase-1 inhibits phosphorylation of the Helicobacter pylori oncoprotein CagA in gastric epithelial cells. Cell. Microbiol. 15, 145-156.
94. Argent, R. H., Kidd, M., Owen, R. J., Thomas, R. J., Limb, M. C., Atherton, J. C. (2004) Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 127, 514-523.
95. Lee, I. O., Kim, J. H., Choi, Y. J., Pillinger, M. H., Kim, S. Y., Blaser, M. J., Lee, Y. C. (2010) Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J. Biol. Chem. 285, 16042-16050.
96. Shibata, W., Takaishi, S., Muthupalani, S., Pritchard, D. M., Whary, M. T., Rogers, A. B., Fox, J. G., Betz, K. S., Kaestner, K. H., Karin, M., Wang, T. C. (2010) Conditional deletion of IκB-kinase-β accelerates Helicobacter-dependent gastric apoptosis, proliferation, and preneoplasia. Gastroenterology 138, 1022. e10-1034. e10.
97. Peng, D-F., Hu, T-L., Schneider, B. G., Chen, Z., Xu, Z-K., El-Rifai, W. (2012) Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas. PLoS One 7, e46214.
98. Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., Gordon, J. I. (2007) The human microbiome project. Nature 449, 804-810.
99. Abreu, M. T., Peek R. M., Jr., (2014) Gastrointestinal malignancy and the microbiome. Gastroenterology 146, 1534. e3-1546. e3.
100. Rolig, A. S., Cech, C., Ahler, E., Carter, J. E., Ottemann, K. M. (2013) The degree of Helicobacter pylori-triggered inflammation is manipulated by preinfection host microbiota. Infect. Immun. 81, 1382-1389.
101. Wu, W. M., Yang, Y. S., Peng, L. H. (2013) The microbiota in stomach: new insights. J. Dig. Dis. 15, 54-61.
102. D'Elia, L., Rossi, G., Ippolito, R., Cappuccio, F. P., Strazzullo, P. (2012) Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin. Nutr. 31, 489-498.
103. Bonequi, P., Meneses-Gonzalez, F., Correa, P., Rabkin, C. S., Camargo, M. C. (2013) Risk factors for gastric cancer in Latin America: a metaanalysis. Cancer Causes Control 24, 217-231.
104. Noto, J. M., Gaddy, J. A., Lee, J. Y., Piazuelo, M. B., Friedman, D. B., Colvin, D. C., Romero-Gallo, J., Suarez, G., Loh, J., Slaughter, J. C., Tan, S., Morgan, D. R., Wilson, K. T., Bravo, L. E., Correa, P., Cover, T. L., Amieva, M. R., Peek, R. M. (2013) Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J. Clin. Invest. 123, 479-492.
105. Cover, T. L., Peek R. M., Jr., (2013) Diet, microbial virulence and Helicobacter pylori-induced gastric cancer. Gut Microbes 4, 6.